September 6, 2023
RegMed Investors’ (RMi) pre-open: risk gets riskier
September 5, 2023
RegMed Investors (RMi) Closing Bell: deep dive to the downside
September 5, 2023
RegMed Investors’ (RMi) pre-open: a challenging September ahead?
September 2, 2023
RegMed Investors (RMi) Closing Bell: September’s first session, a positive close
August 31, 2023
RegMed Investors (RMi) Closing Bell: the match was lit on August’s last trading session
August 30, 2023
RegMed Investors (RMi) Closing Bell: the myth and the reality of sector share pricing
August 29, 2023
RegMed Investors (RMi) Closing Bell: slippage
August 28, 2023
RegMed Investors (RMi) Closing Bell: the music slowed eliminating downside
August 25, 2023
RegMed Investors (RMi) Closing Bell: sector takes the line of least expectation as sector turns positive
August 24, 2023
Med Investors (RMi) Closing Bell: Nasdaq evaporates taking cell and gene therapy equities with it
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.